Ivermectin in veterinary medicine: a narrative review of antiparasitic efficacy, resistance evolution, antiviral evidence, and One Health implications
Matthew T. J. Halma, Joseph Varon, Valeria Garcia, Sidra Hassaan, Jack Tuszynski · 2026
Read Ivermectin in veterinary medicine: a narrative review of antiparasitic efficacy, resistance evolution, antiviral evidence, and One Health implications by Matthew T. J. Halma, Joseph Varon, Valeria Garcia, Sidra Hassaan, Jack Tuszynski (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272313.txt.
Description
Matthew T J Halma and coauthors review in 2026 the use of ivermectin in animal medicine, weighing parasite control against resistance and harm to nature. The drug paralyzes many parasites by opening chloride channels in their nerves and muscles. The authors gathered studies from 1980 to 2025 across four large databases.
Proven anti-parasite uses rest on the strongest proof, though results vary with the parasite, the host animal, the drug form, and local resistance. Claims of antiviral effects rest mostly on lab work, with no proven value in animal patients. Drug traces in dung and soil can harm wild insects, so the authors urge careful dosing and checks for resistance.
Catalog record
| CREATOR | Matthew T. J. Halma, Joseph Varon, Valeria Garcia, Sidra Hassaan, Jack Tuszynski |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |